Cite
MLA Citation
M. Sticherling et al.. “Secukinumab is superior to fumaric acid esters in treating patients with moderate‐to‐severe plaque psoriasis who are naive to systemic treatments: results from the randomized controlled PRIME trial.” British journal of dermatology, vol. 177, 2017, pp. 1024–1032. http://access.bl.uk/ark:/81055/vdc_100052800745.0x000058